Moderna's Cancer Vaccine May Cut Deaths In Half | The Brainstorm 146
ARK Invest · 26:40
ARK's podcast covers two unrelated stories: Moderna/Merck's individualized mRNA cancer vaccine hitting a positive Phase 3 readout in melanoma (a custom-built, per-patient therapy that trains the immune system against...